2019
DOI: 10.1002/smll.201903147
|View full text |Cite
|
Sign up to set email alerts
|

Enhanced In Vivo Delivery of Stem Cells using Microporous Annealed Particle Scaffolds

Abstract: Delivery to the proper tissue compartment is a major obstacle hampering the potential of cellular therapeutics for medical conditions. Delivery of cells within biomaterials may improve localization, but traditional and newer void‐forming hydrogels must be made in advance with cells being added into the scaffold during the manufacturing process. Injectable, in situ cross‐linking microporous scaffolds are recently developed that demonstrate a remarkable ability to provide a matrix for cellular proliferation and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
95
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
1
1

Relationship

3
4

Authors

Journals

citations
Cited by 88 publications
(96 citation statements)
references
References 49 publications
(62 reference statements)
1
95
0
Order By: Relevance
“…Our current method to fabricate MAP scaffolds for use in vivo utilizes the coagulation enzyme FXIIIa, which is a transglutaminase. [ 2,5,11 ] The HMPs are packed and linked between K and Q peptides, recognized by FXIIIa, on their surface. For applications in wound healing, polyethylene glycol (PEG) HMPs annealed with FXIIIa in situ have been shown to promote cutaneous tissue regeneration by supporting cell migration and support tissue structure formation.…”
Section: Figurementioning
confidence: 99%
“…Our current method to fabricate MAP scaffolds for use in vivo utilizes the coagulation enzyme FXIIIa, which is a transglutaminase. [ 2,5,11 ] The HMPs are packed and linked between K and Q peptides, recognized by FXIIIa, on their surface. For applications in wound healing, polyethylene glycol (PEG) HMPs annealed with FXIIIa in situ have been shown to promote cutaneous tissue regeneration by supporting cell migration and support tissue structure formation.…”
Section: Figurementioning
confidence: 99%
“…The Segura lab also demonstrated this concept in vivo, where stiffness, degradability, and adhesive ligand concentration could all be varied to control the immunogenic response and cell infiltration into the porous scaffold. [135] Microgel scaffold modulus has been varied from several Pascals (Pa) for endothelial cell network formation, [134] several hundred Pascals to match vocal fold tissue strength, [64] several kPa for differentiation of stem cell spheroids, [136] to several MPa in doubly cross-linked networks for supporting degenerated intervertebral discs. [137] The wide range of achievable mechanics, as well as the ability to independently tune multiple parameters, demonstrate how microgel mechanics can be designed to mimic the ECM of specific tissues in order to optimize culture for specific cell types.…”
Section: Scaffold Propertiesmentioning
confidence: 99%
“…Scaffold properties (e.g., stiffness, degradability, and ligand presentation) can be modified to tune the regenerative properties and biological response to the material ( Figure 5B). [135] As microgels serve as individual building blocks in assembled scaffolds and may be tuned and functionalized independently, this approach may be exploited to include multiple different cues within a single scaffold for rapid wound healing. While microgel assembled networks have been used sparingly for in vivo applications, their inherent porosity can provide immediate advantages for regenerating tissue more effectively compared to bulk injectable materials.…”
Section: Assembled Microgelsmentioning
confidence: 99%
“…The stroke model was performed as previously described. Briefly, a permanent cortical photothrombotic stroke was induced on young adult C57BL/6 male mice (8)(9)(10)(11)(12) weeks) obtained from Jackson laboratories (Bar Harbor, ME). The mice were anesthetized with 5% isoflurane and placed in a stereotactic setup.…”
Section: Resultsmentioning
confidence: 99%
“…Our current method to fabricate MAP scaffolds for use in vivo utilizes the coagulation enzyme FXIIIa, which is a transglutaminase 2,5,11 . The HMPs are packed and linked between K and Q peptides, recognized by FXIIIa, on their surface.…”
Section: Introductionmentioning
confidence: 99%